NCT00833079 Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT00832585 Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT00828412 Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT00826592 Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis Status COMPLETED Phase NA
NCT00822783 Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients Status COMPLETED Phase PHASE4
NCT00822276 The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) Status COMPLETED Phase N/A
NCT00820820 IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis Status COMPLETED Phase NA
NCT00815984 Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases Status COMPLETED Phase N/A
NCT00810862 Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children Status TERMINATED Phase PHASE4
NCT00809172 Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients Status COMPLETED Phase PHASE3
NCT00806221 An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT00801957 Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT00795496 Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up Status COMPLETED Phase N/A
NCT00789880 Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 Status COMPLETED Phase PHASE2
NCT00757042 Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT00753805 Dietetic Effects of Mare's Milk in Patients With Atopic Dermatitis Status COMPLETED Phase NA
NCT00723489 Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis Status COMPLETED Phase PHASE1/PHASE2
NCT00721331 A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers Status COMPLETED Phase PHASE1